Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin eyes $90K-$93K as Fed rate hike odds drop and ETF inflows support price, but $87.4K resistance remains key.

Analyst Insights
05 Oct 2026
Crypto news
View Source
Bullish
Bitcoin eyes $90K-$93K as Fed rate hike odds drop and ETF inflows support price, but $87.4K resistance remains key.

Bitcoin's potential rise to $90,000-$93,000 depends on easing Treasury yields and inflation data supporting weaker employment, following a drop in October Fed rate hike odds from 64% to 23%. Despite $2.65 billion in U.S. spot Bitcoin ETF inflows in September, Bitcoin struggles to hold above $87,000, indicating sellers are absorbing demand. A daily or weekly close above $87,400 is needed to confirm a breakout, with downside support at $84,000 and $82,000. Risks include stronger inflation, hawkish Fed guidance, and rising yields that could push Bitcoin lower.

Bitcoin's recent market context includes a mixed breadth among major cryptocurrencies on Pluang, with 29 rising and 20 falling out of 50 priced assets. Notable movers as of Oct 06, 2026 04:24 WIB include SAND down 7.07% with a typical hold time of 123 days and a 52% sell order activity, ZIL up 4.26% with a 100% buy order activity and a typical hold time of 133 days, and ONE down 4.01% with a 66% buy order activity and a typical hold time of 152 days. This snapshot provides insight into current market dynamics alongside Bitcoin's price challenges around $87,000.

More News

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital eyes $1B net income by 2027 amid AI data center expansion, Q1 loss expected.

Applied Digital is set to report a fiscal Q1 loss of $0.30 per share on $116.3 million revenue, reflecting ongoing investments in AI and high-performance data centers. The company has expanded its Polaris Forge 1 campus to 250 MW operational capacity...

Company Fundamentals
Bullish
1 hour ago
Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Needham raises Vaxcyte price target after strong Phase 3 trial of VAX-31 vaccine

Investment firm Needham increased its price target for Vaxcyte to $122 from $110 following positive Phase 3 trial results for Vaxcyte's VAX-31 pneumococcal vaccine. The vaccine met all primary endpoints in the OPUS-1 trial, showing noninferiority to ...

Analyst Insights
Bullish
2 hours ago
GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's Rina-S shows 45.9% response in ovarian cancer trial, advancing to Phase 3 studies.

GMAB's investigational drug Rina-S demonstrated a 45.9% confirmed response rate in a Phase 1/2 trial for platinum-resistant ovarian cancer, with a median response duration of 12.1 months and median progression-free survival of 9.5 months. Despite ser...

Market News
Bullish
3 hours ago
The Ritz-Carlton Naples, Tiburón unveils a multi-million-dollar resort redesign with new dining and event spaces.

The Ritz-Carlton Naples, Tiburón unveils a multi-million-dollar resort redesign with new dining and event spaces.

The Ritz-Carlton Naples, Tiburón has completed a multi-million-dollar transformation featuring refreshed accommodations, a redesigned lobby, an elevated Club Lounge, and new culinary venues including Palmera, Fenrose, and Café Fenrose. The redesign e...

Others
Neutral
4 hours ago
US Treasury drops two crypto surveillance rules, marking a win for privacy but keeping existing exchange checks.

US Treasury drops two crypto surveillance rules, marking a win for privacy but keeping existing exchange checks.

The US Treasury's Financial Crimes Enforcement Network (FinCEN) withdrew two proposed rules that would have required banks and exchanges to report users involved in crypto mixing and self-custody wallet transactions. This move is seen as a significan...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App